featured
Safety and Efficacy of Subcutaneous Night-Time–Only Apomorphine Infusion to Treat Insomnia in Patients With Parkinson's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study
Lancet Neurol 2022 May 01;21(5)428-437, VC De Cock, P Dodet, S Leu-Semenescu, C Aerts, G Castelnovo, B Abril, S Drapier, H Olivet, AG Corbillé, L Leclair-Visonneau, M Sallansonnet-Froment, M Lebouteux, M Anheim, E Ruppert, N Vitello, A Eusebio, I Lambert, A Marques, ML Fantini, D Devos, C Monaca, N Benard-Serre, S Lacombe, M Vidailhet, I Arnulf, M Doulazmi, E RozeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.